Yearly Archives: 2022
Halia Therapeutics Promotes Targeting the NLRP3 Inflammasome for Alzheimer’s Disease Treatment
Halia Therapeutics, the first biotechnology company to target NEK7 to block the assembly of the NLRP3 inflammasome complex, participated today in a fireside chat exploring approaches to innovate Alzheimer’s therapies at InformaConnect’s Therapeutic Focus-Neurology digital conference. “There is very little help available for people suffering from neuroinflammatory diseases, such as Alzheimer’s (AD). We do know […]
Renalytix Business Update
Based on recently secured private payer and Medicaid insurance coverage contracts for KidneyIntelX, Renalytix plc is disclosing that the upper Midwest region of the United States, and specifically Illinois and Iowa, are now primary commercial expansion markets. Private insurance coverage contracts secured and effective during the quarter ending September 30, 2022 include Blue Cross Blue […]
Nomi Health Adds Access to Novavax COVID Vaccine in Utah
Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, has expanded its COVID vaccine services with the addition of the Novavax vaccine, now available at the West Valley Nomi Health location. In addition to Novavax, this location also distributes Pfizer, Moderna and Johnson & Johnson vaccines. All […]
Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform Granted by the U.S. Patent Office
Transit Scientific, a Utah-based medical device company, today announced additional U.S. patent protection has been issued from the United States Patent and Trademark Office (USPTO) for its XO exoskeleton sheath platform. Traditional PTA cutting, scoring, and constraining structure (CS) technologies are manufactured with metal or polymer wires, struts, blades, or grooves wrapped around, or fused to, the outside of the angioplasty balloon. These […]
Senate Passes Inflation Reduction Act – Sens. Lee, Romney Oppose
After an all-night session, the Senate on Sunday passed a sweeping, $740 billion reconciliation package titled the “Inflation Reduction.” The measure passed on a party line 51-50 vote, with Vice President Kamala Harris breaking the tie vote. The 755-page bill will now be taken up by the House today, where it is expected to pass […]
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physicians
98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b. Published study complements KidneyIntelX clinical utility data published at American Diabetes Association Annual Conference demonstrating improvements in guideline recommended care, including therapeutic managements and specialist consultation […]
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia
Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics has announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336, an investigational small molecule inhibitor against the binding of menin and mixed-lineage leukemia (MLL) protein, for the treatment of acute myeloid leukemia (AML). “We are pleased to have […]
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update
PolarityTE provided a business update and reported financial results for the quarterly period ended June 30, 2022.
Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336.
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
Modern design advances patient care by combining hemostasis with innovative cooling capability
